Litcius/Paper detail

Lymphocyte Subset Counts in <scp>COVID</scp>‐19 Patients: A Meta‐Analysis

Wei Huang, Julie Bérubé, Michelle McNamara, Suraj Saksena, Marsha Hartman, Tariq Arshad, Scott J. Bornheimer, Maurice R.G. O’Gorman

2020Cytometry Part A250 citationsDOIOpen Access PDF

Abstract

A reduced peripheral blood absolute lymphocyte count with an elevated neutrophil count has been a consistent observation in hospitalized coronavirus disease 2019 (COVID-19) patients. In this brief meta-analysis, the reduction of lymphocyte subset counts in COVID-19 patients was investigated across 20 peer-reviewed studies meeting criteria for reporting lymphocyte subset counts and COVID-19 disease severity. CD4+ T cell, CD8+ T cell, B cell, NK cell, and total lymphocyte cell counts all showed statistically significant reduction in patients with severe/critical COVID-19 disease compared to mild/moderate disease. T-cell subsets showed the largest standardized magnitude of change. In some studies, multivariate analysis has shown that CD4 and/or CD8 T-cells counts are independently predictive of patient outcomes. © 2020 International Society for Advancement of Cytometry.

Topics & Concepts

LymphocyteCD8Coronavirus disease 2019 (COVID-19)Flow cytometryImmunologyMedicinePeripheral blood lymphocyteMeta-analysisLymphocyte subsetsInternal medicineDiseaseImmune systemInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchInflammatory Biomarkers in Disease Prognosis
Lymphocyte Subset Counts in <scp>COVID</scp>‐19 Patients: A Meta‐Analysis | Litcius